Description
The abstract reports that CHCHD6 reduction induces neuronal cholesterol accumulation which promotes amyloid pathology, but the mechanistic link between cholesterol dysregulation and enhanced amyloidogenesis is not explained. Understanding this connection could reveal new therapeutic targets for modulating amyloid production.
Gap type: unexplained_observation Source paper: A CHCHD6-APP axis connects amyloid and mitochondrial pathology in Alzheimer’s disease. (2022, Acta neuropathologica, PMID:36104602)